Securities fraud litigation history and active cases
Active Cases
1
Pending Settlement
1
Closed
0
Total Settlement
$30M
2:26cv803 • February 6, 2026
Class Period Start
October 10, 2023
Class Period End
December 26, 2025
PSLRA Deadline
April 7, 2026
Case Allegations
10b5
Statutes of Repose
Oct 10, 2026
Country
United States
Court
Federal Court
INOVIO PHARMACEUTICALS, INC. (INO) Class Action Lawsuit (March 2020)Pending Settlement
2:20cv1402 • March 12, 2020
Class Period Start
February 13, 2020
Class Period End
November 6, 2020
PSLRA Deadline
May 12, 2020
Case Allegations
10b5
Statutes of Repose
Feb 13, 2023
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
December 19, 2022
Settlement Fund
$30,000,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) from February 14, 2020 through August 10, 2020, inclusive.
Claim Administrator
Gilardi & Co. LLC
Inovio Securities Litigation
Claims Administrator
c/o Gilardi & Co. LLC
P.O. Box 6162
Novato, CA 94948-6162
+1 866-809-3338
[email protected]
Settlement Website
www.InovioSecuritiesLitigation.comHearing Date
December 15, 2022
Opt-out Deadline
November 23, 2022
Settlement Note
Download hereProof Of Claim
Download hereDocket History
TOP